AXNX
Price:
$70.98
Market Cap:
$3.63B
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products throu...[Read more]
Industry
Medical - Devices
IPO Date
2018-10-31
Stock Exchange
NASDAQ
Ticker
AXNX
According to Axonics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -709.80. This represents a change of -93.26% compared to the average of -10533.59 of the last 4 quarters.
The mean historical PE Ratio of Axonics, Inc. over the last ten years is -82.35. The current -709.80 PE Ratio has changed 86.10% with respect to the historical average. Over the past ten years (40 quarters), AXNX's PE Ratio was at its highest in in the December 2022 quarter at 1.13K. The PE Ratio was at its lowest in in the September 2024 quarter at -42330.12.
Average
-82.35
Median
-22.97
Minimum
-501.70
Maximum
-3.26
Discovering the peaks and valleys of Axonics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 925.99%
Maximum Annual PE Ratio = -3.26
Minimum Annual Increase = -78.93%
Minimum Annual PE Ratio = -501.70
Year | PE Ratio | Change |
---|---|---|
2023 | -501.70 | 925.99% |
2022 | -48.90 | 62.32% |
2021 | -30.13 | -10.39% |
2020 | -33.62 | 239.47% |
2019 | -9.90 | 204.23% |
2018 | -3.26 | -78.93% |
2017 | -15.45 | -2.36% |
The current PE Ratio of Axonics, Inc. (AXNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-193.57
5-year avg
-124.85
10-year avg
-82.35
Axonics, Inc.’s PE Ratio is less than Orthofix Medical Inc. (0), less than NuVasive, Inc. (-5.61), less than Glaukos Corporation (56.43), less than Heska Corporation (-55.64), less than Bruker Corporation (-67.36), less than Integer Holdings Corporation (28.29), less than CONMED Corporation (39.94), less than LivaNova PLC (16.37), less than iRhythm Technologies, Inc. (107.29), less than OrthoPediatrics Corp. (-18.54), less than Pulmonx Corporation (-18.39), less than SI-BONE, Inc. (-4.24), less than NeuroPace, Inc. (-14.80), less than Integra LifeSciences Holdings Corporation (-11.68), less than Monogram Orthopaedics, Inc. (-258.53), less than Nano-X Imaging Ltd. (-5.30), less than Medtronic plc (-8.35), less than null (24.39),
Company | PE Ratio | Market cap |
---|---|---|
0 | $662.63M | |
-5.61 | $2.08B | |
56.43 | $8.34B | |
-55.64 | $1.31B | |
-67.36 | $8.83B | |
28.29 | $4.52B | |
39.94 | $2.16B | |
16.37 | $2.54B | |
107.29 | $2.80B | |
-18.54 | $546.67M | |
-18.39 | $243.25M | |
-4.24 | $556.52M | |
-14.80 | $332.51M | |
-11.68 | $1.71B | |
-258.53 | $88.87M | |
-5.30 | $414.18M | |
-8.35 | $104.56B | |
24.39 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axonics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Axonics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Axonics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Axonics, Inc. (AXNX)?
What is the highest PE Ratio for Axonics, Inc. (AXNX)?
What is the 3-year average PE Ratio for Axonics, Inc. (AXNX)?
What is the 5-year average PE Ratio for Axonics, Inc. (AXNX)?
How does the current PE Ratio for Axonics, Inc. (AXNX) compare to its historical average?